First-in-Human, Multiple Part Clinical Study of JNT-517 in Healthy Participants and in Participants With Phenylketonuria
Clinical trial NCT05781399 · COMPLETED
Trial details
- NCT number
- NCT05781399
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-31
- Primary completion
- 2025-07-29
- Enrollment
- 163
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.